Lee, Su Yeon
Park, Mi Hyeon
Oh, Dong Kyu
Lim, Chae-Man
,
Hong, Sang-Bum
Suh, Gee Young
Jeon, Kyeongman
Ko, Ryoung-Eun
Cho, Young-Jae
Lee, Yeon Joo
Lim, Sung Yoon
Park, Sunghoon
Heo, Jeongwon
Lee, Jae-myeong
Kim, Kyung Chan
Chang, Youjin
Lee, Sang-Min
Hong, Suk-Kyung
Cho, Woo Hyun
Kwak, Sang Hyun
Lee, Heung Bum
Ahn, Jong-Joon
Seong, Gil Myeong
Lee, Song-I.
Park, Tai Sun
Lee, Su Hwan
Choi, Eun Young
Moon, Jae Young
Kang, Hyung Koo
Funding for this research was provided by:
Korea Disease Control and Prevention Agency (2019E280500, 2020E280700, 2021-10-026, 2019E280500, 2020E280700, 2021-10-026, 2019E280500, 2020E280700, 2021-10-026, 2019E280500, 2020E280700, 2021-10-026, 2019E280500, 2020E280700, 2021-10-026)
Article History
Received: 12 July 2023
Accepted: 13 February 2024
First Online: 5 March 2024
Declarations
:
: The study protocol was reviewed and approved by the Institutional Review Board at Asan Medical Center (IRB number: 2018–1152; study title: Korean Sepsis Alliance registry: A multicenter observational cohort study; approval date: June 12, 2018), which waived the requirement for informed consent due to the observational nature of this study. Procedures were followed in accordance with the ethical standards of the responsible institutional committee on human experimentation and with the Helsinki Declaration of 1975.
: Not applicable.
: The authors declare no competing interests.